Table 2 AKAP3 expression and clinico-pathologic data. Statistical association between clinico-pathologic data and AKAP3 expression in tumor and normal adjacent tissue

   Negative

27 (67.5)

13 (32.5)

0.4

21 (55.3)

17 (44.7)

0.5

   Positive

20 (62.5)

12 (37.5)

17 (53.1)

15 (46.9)

   Negative

30 (63.8)

17 (36.2)

0.4

24 (53.3)

21 (46.7)

0.5

   Positive

17 (68)

8 (32)

14 (56)

11 (44)

   Negative

34 (68)

16 (32)

0.3

25 (51)

24 (49)

0.2

   Positive

13 (59.1)

9 (40.9)

13 (61.9)

8 (38.1)

   1

3 (50)

3 (50)

0.7

3 (50)

3 (50)

0.9

   2

21 (61.8)

13 (38.2)

18 (52.9)

16 (47.1)

   3

18 (66.7)

9 (33.3)

14 (56)

11 (44)

   No

15 (68.2)

7 (31.8)

0.7

10 (45.5)

12 (54.5)

0.3

   1-3

13 (56.5)

10 (43.5)

11 (47.8)

12 (52.2)

   4-9

8 (57.1)

6 (42.9)

9 (75)

3 (25)

   >9

7 (70)

3 (30)

6 (60)

4 (40)

   ≤2cm

10 (41.7)

14 (58.3)

0.01

13 (54.2)

11 (45.8)

0.5

   >2 cm

32 (72.7)

12 (27.3)

23 (54.8)

19 (45.2)

   I

1 (14.3)

6 (85.7)

0.04

2 (28.6)

5 (71.4)

0.2

   II

22 (66.7)

11 (33.3)

16 (48.5)

17 (51.5)

   III

14 (66.7)

7 (33.3)

12 (63.2)

7 (36.8)

   IV

6 (75)

2 (25)

6 (75)

2 (25)

   Triple Negative

20 (80)

5 (20)

0.03

13 (54.2)

11 (45.8)

0.5

   Other types

27 (56.3)

21 (43.8)

26 (55.3)

21 (44.7)

   No event

31 (63.3)

18 (36.7)

0.5

19 (41.3)

27 (58.7)

0.003

   With event

14 (66.7)

7 (33.3)

16 (80)

4 (20)